FDA Investigator Robert W Calais
Robert W Calais has inspections in 13 countries as of 01 Nov 2023. Robert W Calais has collaborated with a combinined 3218 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
161
Last Inspection Date:
01 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
Canada,
Viet Nam,
United States of America,
Spain,
Italy,
Argentina,
Poland,
Thailand,
United Kingdom of Great Britain and Northern Ireland,
France,
Iceland,
Switzerland
Co-Investigator(s):
Aaron F Coleman,
Albert A Salvador,
Alec D Fabus,
Alec M O'neal,
Andrew I Carr,
Andrew J Mcguffin,
Angela F Orozco,
Antoinette L Ravelli,
Ashley A Mutawakkil,
Ashley A Segura,
Ashley B Jelonek,
Ashley Gonzalez,
Barbara T Carmichael,
Benita C Okeke,
Betsy C Galliher,
Bill Tacket, Jr,
Brandi L Garbutt,
Brant M Schroeder,
Brian M Palermo,
Brian R Yaun,
Brian Ravitch,
Brunilda Torres,
Carol A Perry,
Carol A Robles,
Cary Greene,
Charles N Dupont,
Charles S Watson,
Cheryl G Scott,
Christian L Witkovskie,
Claire M Minden,
Clara E Santiago,
Clausnitzer,
Craig P Seaborn,
Daniel W Johnson,
Darcy L Webber,
Dariusz Galezowski,
David P King,
Deborah A Racioppi,
Deborah K Richardson,
Decima L Thompson,
Devon Jenkins,
Dhaval H Patel,
Diana L Kelsch,
Dillard H Woody, Jr,
Dionne D Arline,
Donald J Mee,
Doreen P Gubbay,
Eduardo Carbonell,
Edward Oshaughnessy,
Edwards,
Elizabeth P Mayer,
Ernest A Clausnitzer,
Ernest L Levins,
Glenn S Quintanilla,
Gobiga Vanniyasingam,
Harry R Bringger, Jr,
Herbert M Corbello,
Herrmann,
Holly M Scott,
Hunt,
Israel Juarbe,
James P Stallings,
Jamie I Espinosa,
Jana L Caylor,
Janaye A Young,
Jasmine M Rueda Fabre,
Jason D Tenney,
Jason P Aun,
Jennifer A Bazergui,
Jennifer A Robinson,
Jennifer Caycedo,
Jennifer L Huntington,
Jesse Ray N Nardone,
Jessica L Pressley,
Jessica M Monteiro,
Jo Annc Declement,
John B Crowe,
Jose N Santiago,
Jose Perez Soto,
Jose R Rodriguez,
Joshua C Schafer,
Joy Rkozlowski Klena,
Juan C Gonzalez Rivera,
Judith A Jones,
Judith A Paterson,
Karen A Spencer,
Karen F Tomaziefski,
Karissa J Mccaw,
Karl D Hezel,
Keith A Schwartz,
Kelly I Anderson,
Kenitra D Hewitt,
King,
Krystyna M Kitson,
Kyle D Covill,
Ladislav Kermet,
Laura B Kennedy,
LCDR Michael H Tollon,
LCDR Randall L Morris,
Leo J Lagrotte,
Leroy Terrelonge,
Leslie A Cartmill,
Leslie A Jackanicz,
Lilly O Barton,
Linda K Matheny,
Lindsay R Hatch,
Lindsay R Mundy,
Lisa A Warner,
Lisa Harlan,
Lissette Paiz,
LT Daveta L Bailey,
LT Kimberly M Hull,
Lura D Kelly,
Madelyn Renteria,
Marcelo O Mangalindan, Jr,
Matthew B Thomaston,
Megan E Kulas,
Melanie G Warzala,
Melinda L Rice,
Melissa B Libby,
Melissa J Hill,
Mendoza,
Meredith L Sheridan,
Meredith M Cobb,
Michael C Lombardi,
Michael E Campbell,
Michael Rosner,
Munoz,
Nancy M Espinal,
Nelson E Venerio,
Nicolas Riveratorres,
Nicole E Knowlton,
Nicole M Bell,
Nympha V Florendo,
Ormond,
Osama M Hamoud,
Paterson,
Patrick J Legler,
Pedro A Cruz,
Quynh H Strandberg,
Ramanda C Gregory,
Raymond Cheung,
Raymond L Cheung,
Regina T Brown,
Remache,
Rene M Amaguana,
Reynolds,
Richard D Manney,
Richard K Vogel,
Rina Bhikha,
Robert C Coleman,
Robert D Ogan,
Robert J Goldman,
Robert J Martin,
Rodney W Lenger,
Ronald T Colucci,
Ruth A Williams,
Salvatore N Randazzo,
Samantha J Pinizzotto, D V M,
Sands,
Sarah K Graham,
Schultz,
Sean D Duke,
Seng Ching Hwang,
Shelton L Stribling,
Sonia D Hudson,
Sonia M Monges,
Stacey F Allard,
Stacey F Rivette,
Stacey L Witherwax,
State Agency,
Stephanie C Milan,
Stephanie T Durso,
Stephen J Mottola,
Susan M Turcovski,
Tegan M Vanartsdalen,
Teigan M Mule,
Teresa M Hillebrandt,
Thomas Cote,
Thomas J Hudson,
Tracy L Reed,
Vernon L O'neil,
Wayne J Meyer,
Wayne L Jefferson,
William J Muszynski,
William W Dotts,
Woody
Robert W Calais's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| September, 2021 | FDA 483 | CerBurg Products Ltd. - Form 483, 2021-09-17 |
| October, 2021 | EIR | RCBA Nutraceuticals LLC - EIR, 2021-10-06 |
| September, 2021 | EIR | CerBurg Products Ltd. - EIR, 2021-09-17 |
| February, 2018 | FDA 483 | Peace River Citrus Products, Inc. - Form 483, 2018-02-20 |
| June, 2022 | FDA 483 | NNS Organics Limited - Form 483, 2022-06-09 |
| September, 2022 | FDA 483 | AZACONSA S.L. - Form 483, 2022-09-22 |
| January, 2016 | EIR | Bravo Packing, Inc. - EIR, 2016-01-28 |
| February, 2018 | EIR | Peace River Citrus Products, Inc. - EIR, 2018-02-20 |
| October, 2015 | EIR | Southport Distribution, LLC - EIR, 2015-10-16 |
| February, 2017 | EIR | Bravo Packing, Inc. - EIR, 2017-02-22 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more